172 related articles for article (PubMed ID: 24135632)
1. 18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28 patients.
Nanni C; Schiavina R; Brunocilla E; Borghesi M; Ambrosini V; Zanoni L; Gentile G; Vagnoni V; Romagnoli D; Martorana G; Fanti S
Clin Genitourin Cancer; 2014 Apr; 12(2):106-10. PubMed ID: 24135632
[TBL] [Abstract][Full Text] [Related]
2. A prospective study on the early evaluation of response to androgen receptor-targeted agents with
Mollica V; Marchetti A; Fraccascia N; Nanni C; Tabacchi E; Malizia C; Argalia G; Rosellini M; Tassinari E; Paccapelo A; Fanti S; Massari F
ESMO Open; 2024 May; 9(5):103448. PubMed ID: 38718704
[TBL] [Abstract][Full Text] [Related]
3. Extended nodal radiotherapy for prostate cancer relapse guided with [11C]-choline PET/CT: ten-year results in patients enrolled in a prospective trial.
Fodor A; Brombin C; Deantoni CL; Giannini L; Ferrario F; Villa SL; Mangili P; Rancoita PMV; Cozzarini C; Picchio M; Del Vecchio A; Fiorino C; Di Serio MCS; Chiti A; Di Muzio NG
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):590-603. PubMed ID: 37747578
[TBL] [Abstract][Full Text] [Related]
4. Dynamic 11C-Choline PET / CT for the primary diagnosis of prostate cancer.
Golan S; Nidam M; Bernstine H; Baniel J; Groshar D
Int Braz J Urol; 2018; 44(5):900-905. PubMed ID: 30088719
[TBL] [Abstract][Full Text] [Related]
5. Evaluating appropriateness of 18F-fluciclovine PET/CT relative to standard of care imaging guidelines and the impact of ADT on positivity: a prospective study in 62 Veterans Administration patients at a single institution.
Green A; Temsah P; Goldfarb L; Sanfolippo K; Knoche E; Muzaffar R; Osman MM
Nucl Med Commun; 2024 Jun; 45(6):526-535. PubMed ID: 38517329
[TBL] [Abstract][Full Text] [Related]
6.
Michaud L; Beattie BJ; Akhurst T; Dunphy M; Zanzonico P; Finn R; Mauguen A; Schöder H; Weber WA; Lassman AB; Blasberg R
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1353-1367. PubMed ID: 31418054
[TBL] [Abstract][Full Text] [Related]
7. Choline PET/CT in Multiple Myeloma.
Mesguich C; Hulin C; Lascaux A; Bordenave L; Marit G; Hindié E
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32481661
[TBL] [Abstract][Full Text] [Related]
8.
Husby T; Johannessen K; Berntsen EM; Johansen H; Giskeødegård GF; Karlberg A; Fagerli UM; Eikenes L
EJNMMI Rep; 2024 Jan; 8(1):2. PubMed ID: 38748286
[TBL] [Abstract][Full Text] [Related]
9. Cavernous Hepatic Hemangioma at 18F-Choline Positron Emission Tomography-Computed Tomography: Be Aware of the Pitfall.
Maffione AM; Urso L; Caterina M; Chondrogiannis S; Grassetto G; Bartoletti P; Marzola MC
Indian J Nucl Med; 2023; 38(4):402-403. PubMed ID: 38390548
[TBL] [Abstract][Full Text] [Related]
10. [
Liberini V; Peano S; Fabbro E; Laudicella R; Papaleo A; Balma M
Nucl Med Mol Imaging; 2024 Feb; 58(1):42-46. PubMed ID: 38261849
[TBL] [Abstract][Full Text] [Related]
11. Initial evaluation of [
Morath V; Heider M; Mittelhäuser M; Rolbieski H; Stroh J; Calais J; Eiber M; Bassermann F; Weber WA
EJNMMI Res; 2022 Jan; 12(1):4. PubMed ID: 35099620
[TBL] [Abstract][Full Text] [Related]
12. Metachronous colon tumor detected utilizing 18F-choline PET/CT in a patient with prostate cancer.
Moreno-Ballesteros A; de la Riva-Pérez PA; Calvo-Morón MC
Rev Gastroenterol Mex (Engl Ed); 2021 Aug; ():. PubMed ID: 34474930
[No Abstract] [Full Text] [Related]
13. 18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT.
Nanni C; Schiavina R; Brunocilla E; Boschi S; Borghesi M; Zanoni L; Pettinato C; Martorana G; Fanti S
Clin Nucl Med; 2015 Aug; 40(8):e386-91. PubMed ID: 26053708
[TBL] [Abstract][Full Text] [Related]
14. Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis.
Turkbey B; Mena E; Shih J; Pinto PA; Merino MJ; Lindenberg ML; Bernardo M; McKinney YL; Adler S; Owenius R; Choyke PL; Kurdziel KA
Radiology; 2014 Mar; 270(3):849-56. PubMed ID: 24475804
[TBL] [Abstract][Full Text] [Related]
15. (18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
Nanni C; Zanoni L; Pultrone C; Schiavina R; Brunocilla E; Lodi F; Malizia C; Ferrari M; Rigatti P; Fonti C; Martorana G; Fanti S
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1601-10. PubMed ID: 26960562
[TBL] [Abstract][Full Text] [Related]
16. Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.
Schuster DM; Nieh PT; Jani AB; Amzat R; Bowman FD; Halkar RK; Master VA; Nye JA; Odewole OA; Osunkoya AO; Savir-Baruch B; Alaei-Taleghani P; Goodman MM
J Urol; 2014 May; 191(5):1446-53. PubMed ID: 24144687
[TBL] [Abstract][Full Text] [Related]
17. Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.
Odewole OA; Tade FI; Nieh PT; Savir-Baruch B; Jani AB; Master VA; Rossi PJ; Halkar RK; Osunkoya AO; Akin-Akintayo O; Zhang C; Chen Z; Goodman MM; Schuster DM
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1773-83. PubMed ID: 27091135
[TBL] [Abstract][Full Text] [Related]
18. Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature.
Yu CY; Desai B; Ji L; Groshen S; Jadvar H
Am J Nucl Med Mol Imaging; 2014; 4(6):580-601. PubMed ID: 25250207
[TBL] [Abstract][Full Text] [Related]
19. Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer.
Akin-Akintayo OO; Jani AB; Odewole O; Tade FI; Nieh PT; Master VA; Bellamy LM; Halkar RK; Zhang C; Chen Z; Goodman MM; Schuster DM
Clin Nucl Med; 2017 Jan; 42(1):e22-e28. PubMed ID: 27749412
[TBL] [Abstract][Full Text] [Related]
20. First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection.
Brunocilla E; Schiavina R; Nanni C; Borghesi M; Cevenini M; Molinaroli E; Vagnoni V; Castellucci P; Ceci F; Fanti S; Gaudiano C; Golfieri R; Martorana G
Arch Ital Urol Androl; 2014 Sep; 86(3):239-40. PubMed ID: 25308599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
